Singapore markets closed

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
18.74-0.30 (-1.58%)
At close: 04:00PM EDT
18.74 0.00 (0.00%)
After hours: 04:04PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts17171920
Avg. Estimate-1.63-1.6-6.25-4.73
Low estimate-2.16-1.97-7.92-7.14
High estimate-0.9-0.86-3.352.56
Year ago EPS-2.46-2.68-9.05-6.25
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts17171920
Avg. Estimate5.73M7.42M37.09M134.8M
Low estimate2.12M2.45M12.05M35.57M
High estimate15.08M15.58M84.71M528.73M
Year ago sales2.41M2.47M86.45M37.09M
Sales growth (year/est)137.80%200.40%-57.10%263.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-2.5-2.55-2.73-1.28
Actual EPS-2.46-2.68-3.37-0.55
Difference0.04-0.13-0.640.73
Surprise %1.60%-5.10%-23.40%57.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.63-1.6-6.25-4.73
7 days ago-1.6-1.58-6.22-4.76
30 days ago-1.6-1.58-6.3-4.9
60 days ago-1.46-1.74-6.14-5.24
90 days ago-1.8-1.86-6.26-5.45
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A11
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSAGEIndustrySector(s)S&P 500
Current qtr.33.70%N/AN/AN/A
Next qtr.40.30%N/AN/AN/A
Current year30.90%N/AN/AN/A
Next year24.30%N/AN/AN/A
Next 5 years (per annum)16.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A